These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1660143)

  • 1. Activation of the erythropoietin receptor promoter by transcription factor GATA-1.
    Zon LI; Youssoufian H; Mather C; Lodish HF; Orkin SH
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10638-41. PubMed ID: 1660143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface.
    Migliaccio AR; Migliaccio G; D'Andrea A; Baiocchi M; Crotta S; Nicolis S; Ottolenghi S; Adamson JW
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11086-90. PubMed ID: 1722318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression.
    Chiba T; Ikawa Y; Todokoro K
    Nucleic Acids Res; 1991 Jul; 19(14):3843-8. PubMed ID: 1650452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA-1 and Sp1 motifs.
    Chin K; Oda N; Shen K; Noguchi CT
    Nucleic Acids Res; 1995 Aug; 23(15):3041-9. PubMed ID: 7659529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gene for erythropoietin receptor is expressed in multipotential hematopoietic and embryonal stem cells: evidence for differentiation stage-specific regulation.
    Heberlein C; Fischer KD; Stoffel M; Nowock J; Ford A; Tessmer U; Stocking C
    Mol Cell Biol; 1992 Apr; 12(4):1815-26. PubMed ID: 1312671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further characterization of cis-acting regulatory sequences in the genomic locus of the murine erythropoietin receptor: evidence for stage-specific regulation.
    Youssoufian H
    Blood; 1994 Mar; 83(5):1428-35. PubMed ID: 8118044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA-1 and erythropoietin receptor genes are highly expressed in erythroleukemia.
    Komatsu N; Kirito K; Izumi T; Eguchi M; Miura Y
    Exp Hematol; 1998 Nov; 26(12):1148-54. PubMed ID: 9808054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactivation of erythroid transcription factor GATA-1 by a myb-ets-containing retrovirus.
    Aurigemma RE; Blair DG; Ruscetti SK
    J Virol; 1992 May; 66(5):3056-61. PubMed ID: 1560536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythroid-specific activation of the distal (testis) promoter of GATA1 during differentiation of purified normal murine hematopoietic stem cells.
    Migliaccio AR; Migliaccio G; Ashihara E; Moroni E; Giglioni B; Ottolenghi S
    Acta Haematol; 1996; 95(3-4):229-35. PubMed ID: 8677748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the erythroid Kruppel-like factor (EKLF) gene promoter by the erythroid transcription factor GATA-1.
    Crossley M; Tsang AP; Bieker JJ; Orkin SH
    J Biol Chem; 1994 Jun; 269(22):15440-4. PubMed ID: 8195185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation.
    Kadri Z; Maouche-Chretien L; Rooke HM; Orkin SH; Romeo PH; Mayeux P; Leboulch P; Chretien S
    Mol Cell Biol; 2005 Sep; 25(17):7412-22. PubMed ID: 16107690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter.
    Tsai SF; Strauss E; Orkin SH
    Genes Dev; 1991 Jun; 5(6):919-31. PubMed ID: 2044960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation.
    Chang TJ; Scher BM; Waxman S; Scher W
    Mol Endocrinol; 1993 Apr; 7(4):528-42. PubMed ID: 8502237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of GATA-1 and EPO receptor genes by a leukemia-inducing retrovirus.
    Ruscetti SK; Aurigemma RE
    Ann N Y Acad Sci; 1994 Apr; 718():245-54; discussion 254-6. PubMed ID: 8185231
    [No Abstract]   [Full Text] [Related]  

  • 15. Transcriptional and posttranscriptional regulation of the expression of the erythropoietin receptor gene in human erythropoietin-responsive cell lines.
    Migliaccio AR; Jiang Y; Migliaccio G; Nicolis S; Crotta S; Ronchi A; Ottolenghi S; Adamson JW
    Blood; 1993 Dec; 82(12):3760-9. PubMed ID: 8260713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cycle-dependent regulation of erythropoietin receptor gene.
    Komatsu N; Kirito K; Kashii Y; Furukawa Y; Kikuchi J; Suwabe N; Yamamoto M; Miura Y
    Blood; 1997 Feb; 89(4):1182-8. PubMed ID: 9028940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
    Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
    Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7.
    Nicolis S; Ottolenghi S; Papayannopoulou T; Baiocchi M; Migliaccio G; Adamson J; Migliaccio AR
    Exp Hematol; 1993 May; 21(5):665-70. PubMed ID: 8513868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF-dependent myeloid cell lines.
    Crotta S; Nicolis S; Ronchi A; Ottolenghi S; Ruzzi L; Shimada Y; Migliaccio AR; Migliaccio G
    Nucleic Acids Res; 1990 Dec; 18(23):6863-9. PubMed ID: 1702202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
    Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
    Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.